Agilent Technologies Inc
NYSE:A
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
124.71
154.64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Agilent Technologies Inc
Agilent Technologies Inc
Selling, General & Administrative
Agilent Technologies Inc
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Agilent Technologies Inc
NYSE:A
|
Selling, General & Administrative
-$1.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-8%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Selling, General & Administrative
-$8.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Danaher Corp
NYSE:DHR
|
Selling, General & Administrative
-$6.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Selling, General & Administrative
-$343.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Selling, General & Administrative
-$922.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
|
Agilent Technologies Inc
Glance View
Agilent Technologies Inc. is a leading global innovator in life sciences, diagnostics, and applied chemical markets, embodying a commitment to advancing scientific discovery and improving healthcare outcomes. Founded in 1999 as a spin-off from Hewlett-Packard, Agilent has strategically positioned itself at the nexus of key industries where powerful analytical tools and technologies are essential. The company's robust portfolio includes sophisticated instruments, software, and services that facilitate groundbreaking research in pharmaceuticals, environmental monitoring, and food safety, making it an indispensable partner for laboratories and research institutions worldwide. With a focus on precision and efficiency, Agilent's solutions enable businesses and scientists to make informed decisions that drive progress in health and safety. Investors are drawn to Agilent not only for its impressive technological capabilities but also for its strong financial performance and a clear growth strategy rooted in innovation and customer collaboration. The company has leveraged its expertise in mass spectrometry, chromatography, and genomics to enhance its offering, tapping into rising trends in personalized medicine and biopharmaceutical development. This dedication to growth is reflected in Agilent's consistent revenue increases and healthy profit margins, underscoring its resilience in a competitive marketplace. As the world increasingly turns toward data-driven approaches in science and healthcare, Agilent stands out as a critical player, promising robust returns for investors seeking exposure to a company that is shaping the future of science and technology.
See Also
What is Agilent Technologies Inc's Selling, General & Administrative?
Selling, General & Administrative
-1.5B
USD
Based on the financial report for Jul 31, 2024, Agilent Technologies Inc's Selling, General & Administrative amounts to -1.5B USD.
What is Agilent Technologies Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-8%
Over the last year, the Selling, General & Administrative growth was 13%. The average annual Selling, General & Administrative growth rates for Agilent Technologies Inc have been 2% over the past three years , -1% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
